Welcome to our dedicated page for Healthstream SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scrolling through HealthStream’s 10-K and 10-Q can feel daunting—especially when you’re hunting for recurring SaaS subscription revenue, segment breakouts between Workforce and Provider Solutions, or acquisition costs buried in footnotes. If you’ve ever Googled “How do I read HealthStream’s annual report 10-K?” or searched for “HealthStream SEC filings explained simply,” this page was built for you.
Stock Titan captures every submission the moment it appears on EDGAR and delivers AI-powered summaries that remove the jargon. That means “understanding HealthStream SEC documents with AI” is finally practical. Need the latest “HealthStream quarterly earnings report 10-Q filing” or a quick brief on “HealthStream 8-K material events explained”? You’ll find them here, alongside plain-English insights into deferred revenue swings, segment margins, and hospital subscriber growth. Our engine also pulls highlights from the “HealthStream proxy statement executive compensation,” connecting CEO bonus metrics to quality-of-care benchmarks.
Governance watchers can follow real-time “HealthStream insider trading Form 4 transactions” without sifting through separate PDFs. Every “HealthStream executive stock transactions Form 4” is tagged, charted, and paired with peer comparisons so you can see buying or selling trends before the market reacts. Whether you want alerts on “HealthStream Form 4 insider transactions real-time,” a digest of “HealthStream earnings report filing analysis,” or a deep dive into the “HealthStream annual report 10-K simplified,” Stock Titan turns dense disclosures into decision-ready knowledge—fast.
Michael M. Collier, Executive Vice President and director at HealthStream, filed a Form 4 reporting a transaction dated 09/24/2025. The filing shows a grant of 2,586 restricted share units (RSUs) that are each convertible into one share of common stock upon vesting. The RSUs follow a four-year service-based vesting schedule: 15% on 09/24/2026, 20% on 09/24/2027, 30% on 09/24/2028, and 35% on 09/24/2029, and were reported as directly owned following the grant.
The Form 4 also reports a reported disposition of 49,482 shares of common stock. The filing was signed by Mr. Collier on 09/26/2025. No exercise price applies to the RSUs and no other derivative instruments or cash amounts are disclosed in this filing.
Kevin P. O'Hara, identified as an Executive Vice President and officer of HealthStream, filed a Form 4 reporting changes in his beneficial ownership of HSTM stock.
The filing shows a reported disposition of 17,137 shares of common stock (listed as "17,137 D" in the non-derivative section). It also reports the acquisition on 09/24/2025 of 2,586 restricted share units (RSUs) at $0 per unit. Each RSU converts to one share upon vesting and is held directly. The RSUs vest over four years contingent on continued service: 15% vests 09/24/2026, 20% vests 09/24/2027, 30% vests 09/24/2028, and 35% vests 09/24/2029.
Jeff Cunningham, Chief Technology Officer of HealthStream, filed a Form 4 reporting an equity award and current stock holdings. The filing shows a grant of 2,069 restricted share units (RSUs) on 09/24/2025, each RSU representing the contingent right to one share of common stock and recorded at a $0 purchase price. The RSUs vest over four years based on continued service: 15% on 09/24/2026, 20% on 09/24/2027, 30% on 09/24/2028, and 35% on 09/24/2029. The form also lists a reported common stock holding of 32,353 shares following the transaction. The filing is signed and dated 09/26/2025.
Michael Scott McQuigg, Senior Vice President and officer of HealthStream, reported transactions on Form 4 for 09/24/2025. The filing shows an award of 2,069 restricted share units (RSUs) granted at $0, each representing the contingent right to receive one share of common stock on vesting. The RSUs follow a four‑year service‑based vesting schedule: 15% on 9/24/2026, 20% on 9/24/2027, 30% on 9/24/2028, and 35% on 9/24/2029. The filing also records a change in non‑derivative common stock holdings showing 27,931 shares with a disposition flag (D). The report is signed 09/26/2025.
Scott Alexander Roberts, CFO and SVP of HealthStream, reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 29,540 shares of common stock and the grant of 2,069 restricted share units (RSUs) on 09/24/2025. Each RSU converts to one share upon vesting under a four‑year schedule: 15% vest 09/24/2026, 20% vest 09/24/2027, 30% vest 09/24/2028 and 35% vest 09/24/2029. The RSUs have a $0 exercise price and are held directly.
Scott Fenstermacher, Senior Vice President at HealthStream, reported insider transactions dated 09/24/2025. The filing records a reported disposal of 16,026 shares of common stock and the acquisition of 1,552 restricted share units (RSUs) granted on 09/24/2025. Each RSU converts to one share upon vesting and the RSUs follow a four-year vesting schedule: 15% on 09/24/2026, 20% on 09/24/2027, 30% on 09/24/2028, and 35% on 09/24/2029. The RSUs were reported as beneficially owned following the transaction: 1,552 shares. The form is signed by Scott Fenstermacher on 09/26/2025.
Form 144 notice for HealthStream, Inc. (HSTM): an individual proposes to sell 2,000 shares of Common Stock08/27/2025.
The filing states the shares were acquired as an RSU award from the issuer on 01/08/2025, paid in full on that date, and the reported aggregate market value of the proposed sale is $56,000. The filer reports 29,641,207 shares outstanding and discloses no sales by the holder in the prior three months. The filer certifies no undisclosed material adverse information.
HealthStream Inc. executive Kevin P. O'Hara reported the sale of 2,000 shares of the company's common stock on 08/27/2025, at a weighted average price of $27.9679 per share (individual trades ranged from $27.79 to $28.10). After the sale, Mr. O'Hara beneficially owned 17,137 shares. The Form 4 identifies Mr. O'Hara as an Executive Vice President and officer of the issuer and shows the filing was signed on 08/27/2025. The disclosure includes an agreement to provide trade-level detail on request and contains no derivative transactions or other securities reported on this form.
FAQ
What is the current stock price of Healthstream (HSTM)?
What is the market cap of Healthstream (HSTM)?
